BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 3066086)

  • 1. Beta-blockers in the management of hypertension in patients with type 2 diabetes mellitus: is there a role?
    Dunne F; Kendall MJ; Martin U
    Drugs; 2001; 61(4):429-35. PubMed ID: 11324677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Penbutolol and carteolol: two new beta-adrenergic blockers with partial agonism.
    Frishman WH; Covey S
    J Clin Pharmacol; 1990 May; 30(5):412-21. PubMed ID: 2189902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Penbutolol: a new beta-adrenergic blocking agent.
    Schlanz KD; Thomas RL
    DICP; 1990 Apr; 24(4):403-8. PubMed ID: 2183495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-blockers in hypertensive non-insulin-dependent diabetics: comparison between penbutolol and propranolol on metabolic control and response to insulin-induced hypoglycemia.
    Marengo C; Marena S; Renzetti A; Mossino M; Pagano G
    Acta Diabetol Lat; 1988; 25(2):141-8. PubMed ID: 3066086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-blind comparison of penbutolol and long-acting propranolol in general practice.
    Hayes G
    Pharmatherapeutica; 1983; 3(7):456-63. PubMed ID: 6366804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single daily dose penbutolol in the treatment of hypertension: a double blind crossover comparison with propranolol.
    Kubik MM; Hanks GW
    Eur J Clin Pharmacol; 1980 Jun; 17(6):409-13. PubMed ID: 6995132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of once daily penbutolol in chronic stable angina. An objective comparison with long-acting propranolol.
    Bowles MJ; Khurmi NS; Bala Subramanian V; Raftery EB
    Int J Cardiol; 1984 Feb; 5(2):131-42. PubMed ID: 6365803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the effects of penbutolol and propranolol on glomerular filtration rate in hypertensive patients with impaired renal function.
    van der Meulen J; Reijn E; Heidendal GA; Oe PL; Donker AJ
    Br J Clin Pharmacol; 1986 Oct; 22(4):469-74. PubMed ID: 3533129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of penbutolol on the hemodynamics in patients with hypertensive disease].
    Demin AA; Mitrokhin VE
    Farmakol Toksikol; 1986; 49(5):74-6. PubMed ID: 3770181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Measurement of glucose assimilation; theoretical principles and practical applications].
    CONARD V
    Acta Gastroenterol Belg; 1955 Sep; 18(9):727-71; contd. PubMed ID: 13275269
    [No Abstract]   [Full Text] [Related]  

  • 11. Penbutolol: a preliminary review of its pharmacological properties and therapeutic efficacy in hypertension and angina pectoris.
    Heel RC; Brogden RN; Speight TM; Avery GS
    Drugs; 1981 Jul; 22(1):1-25. PubMed ID: 7261952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased incidence of retinopathy in diabetics with elevated blood pressure. A six-year follow-up study in Pima Indians.
    Knowler WC; Bennett PH; Ballintine EJ
    N Engl J Med; 1980 Mar; 302(12):645-50. PubMed ID: 6986550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poor metabolic control, hypertension and microangiopathy independently increase the transcapillary escape rate of albumin in diabetes.
    O'Hare JA; Ferriss JB; Twomey B; O'Sullivan DJ
    Diabetologia; 1983 Sep; 25(3):260-3. PubMed ID: 6642091
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.